Groundbreaking clinical trials by London-based start-up Lindus Health have begun to find innovative treatments for conditions such as tinnitus, insomnia and progressive childhood myopia. The company aims to use an industry-first technology platform and machine learning to manage start-to-finish clinical trials, helping therapeutics reach patients faster and improve and extend life. .
Image Credits: Lindas Health
The news comes from investors including FirstMinute, Seedcamp, and Peter Thiel (PayPal co-founder and Facebook’s first outside investor) to drive the company’s use of machine learning and data science. It was announced in the midst of announcing that it had raised $10,000. Revolutionize clinical trials.
Lindas Heath also said their work in machine learning and data science was ‘a highly valuable and game-changing project’ by UKRI evaluators.
Lindus Health’s pioneering technology accelerates treatment approval and time to market, with clinical trials completed three times faster than previous industry standards.
Lindus Health, which has already conducted more than 80 treatment trials in the US, UK and Europe, will next collaborate with global healthcare company Pharmanovia to make the treatment safe and effective for patients with severe insomnia. Evaluate in a global environment. Leverage digital technology to find out-of-reach insomniacs. And they plan to work with Oto to conduct a 200-person trial to evaluate a digital tinnitus solution versus face-to-face therapy.
They are also partnering with Berlin-based startup Dopavision to test a MyopiaX treatment for children with progressive myopia. It aims to increase dopamine levels in the retina and slow the progression of symptoms.
This year, Lindus Health launched a trial with George Medicines aimed at treating and reversing type 2 diabetes, and with US-based Bonafide Health (parent company – JDS Therapeutics) to treat menopausal symptoms. A trial aimed at alleviating it will also be initiated.
Founded in 2021 by Michael Young and Meri Beckwith, Lindus Health is already working with 20,000 patients to find new treatments for chronic diseases.
Clinical trials are the biggest bottleneck in improving human health. We work with high-growth companies developing the next wave of breakthrough therapies to accelerate the clinical trial process.
It’s exciting to work with government and industry pioneers to revolutionize clinical trials and bring treatments that benefit patients faster.
From monitoring trial data in real time to using machine learning to predict trial outcomes and proactively improve trial design, we simplify and accelerate the trial process and put patients first. I would like to. ”
Michael Young, co-founder of Lindus Health.
